Graham Capital Management, L.P. Arvinas, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Arvinas, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 301,304 shares of ARVN stock, worth $2.02 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
301,304
Previous 87,879
242.86%
Holding current value
$2.02 Million
Previous $1.68 Million
25.59%
% of portfolio
0.05%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding ARVN
# of Institutions
246Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$55.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$41.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$25.9 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$25.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$22.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $356M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...